A CASE OF EXTRAGONADAL GERM-CELL TUMOR WITH ELEVATED POSTCHEMOTHERAPYHCG SUCCESSFULLY TREATED BY RESECTION OF A SOLITARY METASTASIS AND CHRONIC ORAL ETOPOSIDE
Citation
T. Ohtsu et al., A CASE OF EXTRAGONADAL GERM-CELL TUMOR WITH ELEVATED POSTCHEMOTHERAPYHCG SUCCESSFULLY TREATED BY RESECTION OF A SOLITARY METASTASIS AND CHRONIC ORAL ETOPOSIDE, Japanese Journal of Clinical Oncology, 26(2), 1996, pp. 107-111
Categorie Soggetti
Oncology
SICI code
0368-2811(1996)26:2<107:ACOEGT>2.0.ZU;2-C
Abstract
We report a 39-year-old man with disseminated extragonadal germ cell t
umor (GCT), whose se rum level of human chorionic gonadotropin (HCG) i
ncreased again after platinum-based combination chemotherapy, high-dos
e chemotherapy with autologous bone marrow rescue and radical adjuncti
ve surgery. The increase in the HCG level was progressive in spite of
multiple chemotherapy, and after a while, a coin lesion in the right l
ung was identified by chest roentgenography. The plumonary lesion was
refractory to additional chemotherapy. After a systemic survey to conf
irm that the lesion was solitary, video-assisted thoracoscopic wedge r
esection of the right lower lobe was performed. Because the resected t
umor included viable tumor cells and the serum HCG level remained slig
htly high one month after the operation, oral low-dose etoposide was b
egun. In a short time, the level of the serum tumor marker decreased a
nd remained normal during the subsequent 7 months of therapy and there
after. The patient remains in complete remission 13 months after compl
etion of the final therapy and 3 years after the initial diagnosis. Ev
en if the level of a serum tumor marker is high, salvage resection can
be a promising therapeutic option for operable tumors that are refrac
tory to chemotherapy. The usefulness of chronic oral etoposide for pat
ients with GCT should be examined by further clinical trials.